Isofol Medical AB (publ) has taken note of the results from the Modelle 001 study
GOTHENBURG, Sweden, October 5, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), announces today that the company has taken notice of the results from the investigator-initiated study Modelle 001.
Dela artikeln
Taggar: isofol, medical, (publ)
Läs vidare på Dagens Industri